Peripheral IV cannulation in chemotherapy administration.
It is well recognized that chemotherapy treatments can result in toxic side effects, some of which can be life threatening, such as bone marrow suppression causing neutropenia, thrombocytopaenia, and/or anaemia. These effects place patients at an increased risk of infection when having peripheral cannula placed for intravenous (IV) therapies. The issues surrounding infection control are therefore of particular significance when caring for this patient group.
McGowan
Donna
D
Edinburgh Cancer Centre, Western General Hospital, Edinburgh.
D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000009:adverse effects; D002406:Catheterization, Peripheral / Q000009:adverse effects / Q000379:methods / Q000451:nursing; D057189:Checklist; D002985:Clinical Protocols; D004868:Equipment Failure; D006801:Humans; D017053:Infection Control; D017410:Practice Guidelines as Topic; D012307:Risk Factors
D000970:Antineoplastic Agents